Applied Materials Announces Third Quarter 2022 Results
- Record quarterly revenue of
$6.52 billion , up 5 percent year over year - GAAP EPS of
$1.85 and non-GAAP EPS of$1.94 , down 1 percent and up 2 percent year over year, respectively - Generated
$1.47 billion in cash from operations and returned$1.23 billion to shareholders
Third Quarter Results
Applied generated revenue of
On a non-GAAP adjusted basis, the company reported gross margin of 46.2 percent, operating income of
The company generated
“Applied Materials delivered record quarterly revenue, yet ongoing supply chain challenges constrained our ability to meet demand, and our top priority remains increasing shipments to our customers,” said
Results Summary
Q3 FY2022 | Q3 FY2021 | Change | |||||||
(In millions, except per share amounts and percentages) | |||||||||
Net sales | $ | 6,520 | $ | 6,196 | 5% | ||||
Gross margin | 46.1 | % | 47.9 | % | (1.8) points | ||||
Operating margin | 29.5 | % | 32.5 | % | (3.0) points | ||||
Net income | $ | 1,606 | $ | 1,716 | (6)% | ||||
Diluted earnings per share | $ | 1.85 | $ | 1.87 | (1)% | ||||
Non-GAAP Adjusted Results | |||||||||
Non-GAAP adjusted gross margin | 46.2 | % | 48.0 | % | (1.8) points | ||||
Non-GAAP adjusted operating margin | 30.0 | % | 32.7 | % | (2.7) points | ||||
Non-GAAP adjusted net income | $ | 1,683 | $ | 1,740 | (3)% | ||||
Non-GAAP adjusted diluted EPS | $ | 1.94 | $ | 1.90 | 2% | ||||
A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial tables included in this release. See also “Use of Non-GAAP Adjusted Financial Measures” section.
Business Outlook
In the fourth quarter of fiscal 2022, Applied expects net sales to be approximately
This outlook for non-GAAP adjusted diluted EPS excludes known charges related to completed acquisitions of
Third Quarter Reportable Segment Information
Semiconductor Systems | Q3 FY2022 | Q3 FY2021 | |||||
(In millions, except percentages) | |||||||
Net sales | $ | 4,734 | $ | 4,454 | |||
Foundry, logic and other | 66 | % | 63 | % | |||
DRAM | 15 | % | 20 | % | |||
Flash memory | 19 | % | 17 | % | |||
Operating income | $ | 1,701 | $ | 1,785 | |||
Operating margin | 35.9 | % | 40.1 | % | |||
Non-GAAP Adjusted Results | |||||||
Non-GAAP adjusted operating income | $ | 1,708 | $ | 1,794 | |||
Non-GAAP adjusted operating margin | 36.1 | % | 40.3 | % |
Applied |
Q3 FY2022 | Q3 FY2021 | |||||
(In millions, except percentages) | |||||||
Net sales | $ | 1,420 | $ | 1,286 | |||
Operating income | $ | 434 | $ | 393 | |||
Operating margin | 30.6 | % | 30.6 | % | |||
Non-GAAP Adjusted Results | |||||||
Non-GAAP adjusted operating income | $ | 434 | $ | 393 | |||
Non-GAAP adjusted operating margin | 30.6 | % | 30.6 | % | |||
Display and Adjacent Markets | Q3 FY2022 | Q3 FY2021 | |||||
(In millions, except percentages) | |||||||
Net sales | $ | 333 | $ | 431 | |||
Operating income | $ | 69 | $ | 99 | |||
Operating margin | 20.7 | % | 23.0 | % | |||
Non-GAAP Adjusted Results | |||||||
Non-GAAP adjusted operating income | $ | 70 | $ | 100 | |||
Non-GAAP adjusted operating margin | 21.0 | % | 23.2 | % | |||
Use of Non-GAAP Adjusted Financial Measures
Applied provides investors with certain non-GAAP adjusted financial measures, which are adjusted for the impact of certain costs, expenses, gains and losses, including certain items related to mergers and acquisitions; restructuring and severance charges and any associated adjustments; certain incremental expenses related to COVID-19; impairments of assets; gain or loss on strategic investments; certain income tax items and other discrete adjustments. On a non-GAAP basis, the tax effect related to share-based compensation is recognized ratably over the fiscal year. Reconciliations of these non-GAAP measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are provided in the financial tables included in this release.
Management uses these non-GAAP adjusted financial measures to evaluate the company’s operating and financial performance and for planning purposes, and as performance measures in its executive compensation program. Applied believes these measures enhance an overall understanding of its performance and investors’ ability to review the company’s business from the same perspective as the company’s management, and facilitate comparisons of this period’s results with prior periods on a consistent basis by excluding items that management does not believe are indicative of Applied's ongoing operating performance. There are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with generally accepted accounting principles, may be different from non-GAAP financial measures used by other companies, and may exclude certain items that may have a material impact upon our reported financial results. The presentation of this additional information is not meant to be considered in isolation or as a substitute for the directly comparable financial measures prepared in accordance with GAAP.
Webcast Information
Forward-Looking Statements
This press release contains forward-looking statements, including those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers, technology transitions, our business and financial performance and market share positions, our capital allocation and cash deployment strategies, our investment and growth strategies, our development of new products and technologies, our business outlook for the fourth quarter of fiscal 2022 and beyond, and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the level of demand for our products, our ability to meet customer demand, and our suppliers' ability to meet our demand requirements; transportation interruptions and logistics constraints; global economic, political and industry conditions, including rising inflation and interest rates; the effects of regional or global health epidemics, including the severity and duration of the ongoing COVID-19 pandemic and government imposed lockdowns and other measures taken in response; global trade issues and changes in trade and export license policies; consumer demand for electronic products; the demand for semiconductors; customers’ technology and capacity requirements; the introduction of new and innovative technologies, and the timing of technology transitions; our ability to develop, deliver and support new products and technologies; the concentrated nature of our customer base; acquisitions, investments and divestitures; changes in income tax laws; our ability to expand our current markets, increase market share and develop new markets; market acceptance of existing and newly developed products; our ability to obtain and protect intellectual property rights in key technologies; our ability to achieve the objectives of operational and strategic initiatives, align our resources and cost structure with business conditions, and attract, motivate and retain key employees; the variability of operating expenses and results among products and segments, and our ability to accurately forecast future results, market conditions, customer requirements and business needs; our ability to ensure compliance with applicable law, rules and regulations; and other risks and uncertainties described in our
About
Contact:
UNAUDITED CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
Three Months Ended | Nine Months Ended | ||||||||||||||
(In millions, except per share amounts) | 2022 |
2021 |
2022 |
2021 |
|||||||||||
Net sales | $ | 6,520 | $ | 6,196 | $ | 19,036 | $ | 16,940 | |||||||
Cost of products sold | 3,514 | 3,229 | 10,144 | 8,971 | |||||||||||
Gross profit | 3,006 | 2,967 | 8,892 | 7,969 | |||||||||||
Operating expenses: | |||||||||||||||
Research, development and engineering | 705 | 640 | 2,045 | 1,863 | |||||||||||
Marketing and selling | 180 | 159 | 520 | 454 | |||||||||||
General and administrative | 197 | 155 | 537 | 465 | |||||||||||
Severance and related charges | — | — | (4 | ) | 158 | ||||||||||
Deal termination fee | — | — | — | 154 | |||||||||||
Total operating expenses | 1,082 | 954 | 3,098 | 3,094 | |||||||||||
Income from operations | 1,924 | 2,013 | 5,794 | 4,875 | |||||||||||
Interest expense | 56 | 57 | 171 | 179 | |||||||||||
Interest and other income (loss), net | (7 | ) | 24 | 27 | 69 | ||||||||||
Income before income taxes | 1,861 | 1,980 | 5,650 | 4,765 | |||||||||||
Provision for income taxes | 255 | 264 | 716 | 589 | |||||||||||
Net income | $ | 1,606 | $ | 1,716 | $ | 4,934 | $ | 4,176 | |||||||
Earnings per share: | |||||||||||||||
Basic | $ | 1.86 | $ | 1.89 | $ | 5.63 | $ | 4.57 | |||||||
Diluted | $ | 1.85 | $ | 1.87 | $ | 5.59 | $ | 4.52 | |||||||
Weighted average number of shares: | |||||||||||||||
Basic | 864 | 908 | 877 | 914 | |||||||||||
Diluted | 869 | 918 | 883 | 923 | |||||||||||
UNAUDITED CONSOLIDATED CONDENSED BALANCE SHEETS
(In millions) | 2022 |
2021 |
|||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 2,956 | $ | 4,995 | |||
Short-term investments | 592 | 464 | |||||
Accounts receivable, net | 4,956 | 4,953 | |||||
Inventories | 5,506 | 4,309 | |||||
Other current assets | 1,424 | 1,386 | |||||
Total current assets | 15,434 | 16,107 | |||||
Long-term investments | 2,047 | 2,055 | |||||
Property, plant and equipment, net | 2,194 | 1,934 | |||||
3,713 | 3,479 | ||||||
Purchased technology and other intangible assets, net | 337 | 104 | |||||
Deferred income taxes and other assets | 2,436 | 2,146 | |||||
Total assets | $ | 26,161 | $ | 25,825 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable and accrued expenses | $ | 4,005 | $ | 4,268 | |||
Contract liabilities | 2,828 | 2,076 | |||||
Total current liabilities | 6,833 | 6,344 | |||||
Long-term debt | 5,456 | 5,452 | |||||
Income taxes payable | 955 | 1,090 | |||||
Other liabilities | 847 | 692 | |||||
Total liabilities | 14,091 | 13,578 | |||||
Total stockholders’ equity | 12,070 | 12,247 | |||||
Total liabilities and stockholders’ equity | $ | 26,161 | $ | 25,825 | |||
UNAUDITED CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(In millions) |
Three Months Ended | Nine Months Ended | |||||||||||||
2022 |
2021 |
2022 |
2021 |
||||||||||||
Cash flows from operating activities: | |||||||||||||||
Net income | $ | 1,606 | $ | 1,716 | $ | 4,934 | $ | 4,176 | |||||||
Adjustments required to reconcile net income to cash provided by operating activities: | |||||||||||||||
Depreciation and amortization | 108 | 98 | 321 | 289 | |||||||||||
Severance and related charges | — | — | (4 | ) | 149 | ||||||||||
Share-based compensation | 95 | 81 | 314 | 272 | |||||||||||
Deferred income taxes | 47 | 20 | (209 | ) | 44 | ||||||||||
Other | 22 | (15 | ) | 14 | (30 | ) | |||||||||
Net change in operating assets and liabilities | (409 | ) | (214 | ) | (828 | ) | (606 | ) | |||||||
Cash provided by operating activities | 1,469 | 1,686 | 4,542 | 4,294 | |||||||||||
Cash flows from investing activities: | |||||||||||||||
Capital expenditures | (210 | ) | (137 | ) | (564 | ) | (462 | ) | |||||||
Cash paid for acquisitions, net of cash acquired | (441 | ) | — | (441 | ) | (12 | ) | ||||||||
Proceeds from sales and maturities of investments | 374 | 400 | 1,013 | 1,024 | |||||||||||
Purchases of investments | (339 | ) | (457 | ) | (1,175 | ) | (1,179 | ) | |||||||
Cash used in investing activities | (616 | ) | (194 | ) | (1,167 | ) | (629 | ) | |||||||
Cash flows from financing activities: | |||||||||||||||
Proceeds from common stock issuances | — | — | 96 | 86 | |||||||||||
Common stock repurchases | (1,000 | ) | (1,500 | ) | (4,603 | ) | (2,250 | ) | |||||||
Tax withholding payments for vested equity awards | (3 | ) | (12 | ) | (259 | ) | (171 | ) | |||||||
Payments of dividends to stockholders | (225 | ) | (219 | ) | (650 | ) | (622 | ) | |||||||
Cash used in financing activities | (1,228 | ) | (1,731 | ) | (5,416 | ) | (2,957 | ) | |||||||
Increase (decrease) in cash, cash equivalents and restricted cash equivalents | (375 | ) | (239 | ) | (2,041 | ) | 708 | ||||||||
Cash, cash equivalents and restricted cash equivalents—beginning of period | 3,435 | 6,413 | 5,101 | 5,466 | |||||||||||
Cash, cash equivalents and restricted cash equivalents — end of period | $ | 3,060 | $ | 6,174 | $ | 3,060 | $ | 6,174 | |||||||
Reconciliation of cash, cash equivalents, and restricted cash equivalents | |||||||||||||||
Cash and cash equivalents | $ | 2,956 | $ | 6,066 | $ | 2,956 | $ | 6,066 | |||||||
Restricted cash equivalents included in deferred income taxes and other assets | 104 | 108 | 104 | 108 | |||||||||||
Total cash, cash equivalents, and restricted cash equivalents | $ | 3,060 | $ | 6,174 | $ | 3,060 | $ | 6,174 | |||||||
Supplemental cash flow information: | |||||||||||||||
Cash payments for income taxes | $ | 592 | $ | 232 | $ | 1,623 | $ | 641 | |||||||
Cash refunds from income taxes | $ | 5 | $ | 3 | $ | 133 | $ | 26 | |||||||
Cash payments for interest | $ | 35 | $ | 34 | $ | 137 | $ | 137 | |||||||
UNAUDITED SUPPLEMENTAL INFORMATION
Corporate and Other
(In millions) | Q3 FY2022 | Q3 FY2021 | |||||
Unallocated net sales | $ | 33 | $ | 25 | |||
Unallocated cost of products sold and expenses | (218 | ) | (208 | ) | |||
Share-based compensation | (95 | ) | (81 | ) | |||
Total | $ | (280 | ) | $ | (264 | ) | |
Additional Information
Q3 FY2022 | Q3 FY2021 | ||||||
$ | 725 | $ | 533 | ||||
% of Total | 11 | % | 9 | % | |||
$ | 529 | $ | 238 | ||||
% of Total | 8 | % | 4 | % | |||
$ | 438 | $ | 449 | ||||
% of Total | 7 | % | 7 | % | |||
$ | 1,224 | $ | 1,291 | ||||
% of Total | 19 | % | 21 | % | |||
$ | 1,537 | $ | 1,261 | ||||
% of Total | 24 | % | 20 | % | |||
$ | 270 | $ | 173 | ||||
% of Total | 4 | % | 3 | % | |||
$ | 1,797 | $ | 2,251 | ||||
% of Total | 27 | % | 36 | % | |||
Employees (In thousands) | |||||||
Regular Full Time | 31.9 | 26.0 | |||||
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP ADJUSTED RESULTS
Three Months Ended | Nine Months Ended | ||||||||||||||
(In millions, except percentages) | 2022 |
2021 |
2022 |
2021 |
|||||||||||
Non-GAAP Adjusted Gross Profit | |||||||||||||||
Reported gross profit - GAAP basis | $ | 3,006 | $ | 2,967 | $ | 8,892 | $ | 7,969 | |||||||
Certain items associated with acquisitions1 | 7 | 6 | 20 | 21 | |||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 12 | |||||||||||
Other charges | — | — | — | 2 | |||||||||||
Non-GAAP adjusted gross profit | $ | 3,013 | $ | 2,973 | $ | 8,912 | $ | 8,004 | |||||||
Non-GAAP adjusted gross margin | 46.2 | % | 48.0 | % | 46.8 | % | 47.2 | % | |||||||
Non-GAAP Adjusted Operating Income | |||||||||||||||
Reported operating income - GAAP basis | $ | 1,924 | $ | 2,013 | $ | 5,794 | $ | 4,875 | |||||||
Certain items associated with acquisitions1 | 10 | 11 | 29 | 36 | |||||||||||
Acquisition integration and deal costs | 19 | 5 | 32 | 40 | |||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 24 | |||||||||||
Severance and related charges3 | — | — | (4 | ) | 158 | ||||||||||
Deal termination fee | — | — | — | 154 | |||||||||||
Other charges | — | — | — | 6 | |||||||||||
Non-GAAP adjusted operating income | $ | 1,953 | $ | 2,029 | $ | 5,851 | $ | 5,293 | |||||||
Non-GAAP adjusted operating margin | 30.0 | % | 32.7 | % | 30.7 | % | 31.2 | % | |||||||
Non-GAAP Adjusted Net Income | |||||||||||||||
Reported net income - GAAP basis | $ | 1,606 | $ | 1,716 | $ | 4,934 | $ | 4,176 | |||||||
Certain items associated with acquisitions1 | 10 | 11 | 29 | 36 | |||||||||||
Acquisition integration and deal costs | 12 | 5 | 28 | 41 | |||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 24 | |||||||||||
Severance and related charges3 | — | — | (4 | ) | 158 | ||||||||||
Deal termination fee | — | — | — | 154 | |||||||||||
Realized loss (gain) on strategic investments, net | (1 | ) | (6 | ) | (1 | ) | (2 | ) | |||||||
Unrealized loss (gain) on strategic investments, net | 18 | (13 | ) | (15 | ) | (45 | ) | ||||||||
Other charges | — | — | — | 6 | |||||||||||
Income tax effect of share-based compensation4 | 22 | 11 | (22 | ) | (12 | ) | |||||||||
Income tax effects related to intra-entity intangible asset transfers | 21 | 23 | 120 | 60 | |||||||||||
Resolution of prior years’ income tax filings and other tax items | 1 | (9 | ) | (54 | ) | (22 | ) | ||||||||
Income tax effect of non-GAAP adjustments5 | (6 | ) | 2 | — | (43 | ) | |||||||||
Non-GAAP adjusted net income | $ | 1,683 | $ | 1,740 | $ | 5,015 | $ | 4,531 |
1 | These items are incremental charges attributable to completed acquisitions, consisting of amortization of purchased intangible assets. |
2 | Temporary incremental employee compensation during the COVID-19 pandemic. |
3 | The severance and related charges primarily related to a one-time voluntary retirement program offered to certain eligible employees. |
4 | GAAP basis tax benefit related to share-based compensation is recognized ratably over the fiscal year on a non-GAAP basis. |
5 | Adjustment to provision for income taxes related to non-GAAP adjustments reflected in income before income taxes. |
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP ADJUSTED RESULTS
Three Months Ended | Nine Months Ended | ||||||||||||||
(In millions, except per share amounts) | 2022 |
2021 |
2022 |
2021 |
|||||||||||
Non-GAAP Adjusted Earnings Per Diluted Share | |||||||||||||||
Reported earnings per diluted share - GAAP basis | $ | 1.85 | $ | 1.87 | $ | 5.59 | $ | 4.52 | |||||||
Certain items associated with acquisitions | 0.01 | 0.01 | 0.03 | 0.03 | |||||||||||
Acquisition integration and deal costs | 0.01 | 0.01 | 0.03 | 0.04 | |||||||||||
Certain incremental expenses related to COVID-19 | — | — | — | 0.02 | |||||||||||
Severance and related charges | — | — | — | 0.13 | |||||||||||
Deal termination fee | — | — | — | 0.17 | |||||||||||
Realized loss (gain) on strategic investments, net | — | (0.01 | ) | — | 0.01 | ||||||||||
Unrealized loss (gain) on strategic investments, net | 0.02 | (0.01 | ) | (0.02 | ) | (0.05 | ) | ||||||||
Other charges | — | — | — | 0.01 | |||||||||||
Income tax effect of share-based compensation | 0.03 | 0.01 | (0.03 | ) | (0.01 | ) | |||||||||
Income tax effects related to intra-entity intangible asset transfers | 0.02 | 0.03 | 0.14 | 0.06 | |||||||||||
Resolution of prior years’ income tax filings and other tax items | — | (0.01 | ) | (0.06 | ) | (0.02 | ) | ||||||||
Non-GAAP adjusted earnings per diluted share | $ | 1.94 | $ | 1.90 | $ | 5.68 | $ | 4.91 | |||||||
Weighted average number of diluted shares | 869 | 918 | 883 | 923 | |||||||||||
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP ADJUSTED RESULTS
Three Months Ended | Nine Months Ended | ||||||||||||||
(In millions, except percentages) | 2022 |
2021 |
2022 |
2021 |
|||||||||||
Semiconductor Systems Non-GAAP Adjusted Operating Income | |||||||||||||||
Reported operating income - GAAP basis | $ | 1,701 | $ | 1,785 | $ | 5,120 | $ | 4,588 | |||||||
Certain items associated with acquisitions1 | 7 | 9 | 22 | 29 | |||||||||||
Acquisition integration costs | — | — | — | (2 | ) | ||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 12 | |||||||||||
Other charges | — | — | — | 3 | |||||||||||
Non-GAAP adjusted operating income | $ | 1,708 | $ | 1,794 | $ | 5,142 | $ | 4,630 | |||||||
Non-GAAP adjusted operating margin | 36.1 | % | 40.3 | % | 37.4 | % | 38.7 | % | |||||||
AGS Non-GAAP Adjusted Operating Income | |||||||||||||||
Reported operating income - GAAP basis | $ | 434 | $ | 393 | $ | 1,259 | $ | 1,083 | |||||||
Certain incremental expenses related to COVID-192 | — | — | — | 8 | |||||||||||
Other charges | — | — | — | 1 | |||||||||||
Non-GAAP adjusted operating income | $ | 434 | $ | 393 | $ | 1,259 | $ | 1,092 | |||||||
Non-GAAP adjusted operating margin | 30.6 | % | 30.6 | % | 30.5 | % | 30.0 | % | |||||||
Display and Adjacent Markets Non-GAAP Adjusted Operating Income | |||||||||||||||
Reported operating income - GAAP basis | $ | 69 | $ | 99 | $ | 226 | $ | 229 | |||||||
Certain items associated with acquisitions1 | 1 | 1 | 3 | 3 | |||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 1 | |||||||||||
Severance and related charges3 | — | — | — | 8 | |||||||||||
Non-GAAP adjusted operating income | $ | 70 | $ | 100 | $ | 229 | $ | 241 | |||||||
Non-GAAP adjusted operating margin | 21.0 | % | 23.2 | % | 21.2 | % | 19.8 | % |
1 | These items are incremental charges attributable to completed acquisitions, consisting of amortization of purchased intangible assets. |
2 | Temporary incremental employee compensation during the COVID-19 pandemic. |
3 | The severance and related charges related to workforce reduction actions globally across the Display and Adjacent Markets business. |
Note: The reconciliation of GAAP and non-GAAP adjusted segment results above does not include certain revenues, costs of products sold and operating expenses that are reported within corporate and other and included in consolidated operating income.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP ADJUSTED EFFECTIVE INCOME TAX RATE
Three Months Ended | |||
(In millions, except percentages) | |||
Provision for income taxes - GAAP basis (a) | $ | 255 | |
Income tax effect of share-based compensation | (22 | ) | |
Income tax effects related to intra-entity intangible asset transfers | (21 | ) | |
Resolutions of prior years’ income tax filings and other tax items | (1 | ) | |
Income tax effect of non-GAAP adjustments | 6 | ||
Non-GAAP adjusted provision for income taxes (b) | $ | 217 | |
Income before income taxes - GAAP basis (c) | $ | 1,861 | |
Certain items associated with acquisitions | 10 | ||
Acquisition integration and deal costs | 12 | ||
Realized loss (gain) on strategic investments, net | (1 | ) | |
Unrealized loss (gain) on strategic investments, net | 18 | ||
Non-GAAP adjusted income before income taxes (d) | $ | 1,900 | |
Effective income tax rate - GAAP basis (a/c) | 13.7 | % | |
Non-GAAP adjusted effective income tax rate (b/d) | 11.4 | % | |
Source: Applied Materials, Inc.